Friday September 30, 2022

Japan becomes first country to approve Ronapreve treatment

July 21, 2021

Geneva: Swiss pharmaceutical giant Roche said Tuesday that Japan had become the first country to fully approve its Ronapreve antibody treatment for patients with mild to moderate Covid-19. The approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid patients would develop into serious illness causing hospitalisation or death.